ClinicalTrials.gg
Drug

Tissue Plasminogen Activator clinical trials

Also written Alteplase, Actilyse, Activase and rt-PA.

studies test it
124
open now
11
in phase 3
45
first study started
1993

Counted the way a researcher would: Tissue Plasminogen Activator with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Tissue Plasminogen Activator is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Tissue Plasminogen Activator studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
13 Nov 1987 · ACTIVASE · BLA 103172 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tissue Plasminogen Activator
21
recombinant tissue plasminogen activator
11
r-tPA
9
Cathflo
5
rtPA
5

Brand

Actilyse
18
Activase
17

Development codes

rt-PA
17
PD-616
1

Other names

Alteplase
50
tPA
16
Plasminogen Activator (Human Tissue-Type Protein Moiety)
1
Alteplase for Injection
1

Studies by the year they started

121 studies that test it; most in 2019 (9); 1 more planned to start later

Studies that test Tissue Plasminogen Activator, by start year
YearStudies
19931
19981
20013
20023
20033
20046
20054
20062
20094
20103
20117
20128
20136
20146
20154
20166
20174
20188
20199
20209
20217
20226
20234
20243
20251
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
14
Phase 2
31
Phase 3
45
Phase 4
23
No phase
16

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 107

Johns Hopkins University (5) · Boehringer Ingelheim (4) · Kafrelsheikh University (3) · Second Affiliated Hospital, School of Medicine, Zhejiang University (3) · Thrombolex, Inc. (3) · Boston Scientific Corporation (3) · Tanabe Pharma Corporation (2) · University of Calgary (2)

Often tested with

Tested in the same studies.

Tenecteplase (7) · Streptokinase (2) · Heparin (2) · auR protein, Staphylococcus aureus (1) · Deoxyribonucleases (1) · Deoxyribonuclease I (1) · Perflutren (1) · Warfarin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Tissue Plasminogen Activator is the comparator. A study of two new drugs counts under both.

  • 1Tenecteplase · Xuanwu Hospital, Beijing · next primary completion Dec 2026
Reaching primary completion within a year · 1

Studies that test Tissue Plasminogen Activator.

Studies

Open first, then newest update. How each study uses Tissue Plasminogen Activator is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 124

See all 124 studies that test Tissue Plasminogen Activator →

Given beside what is tested · 15 — Tissue Plasminogen Activator is usual care or a partner of the new treatment
As the comparator · 32 — what is tested is compared with Tissue Plasminogen Activator

Showing 20 of 32.

What changed recently

From the registry's own updates since Oct 20, 2026.

Newly registered1

Codes

What other systems call Tissue Plasminogen Activator · ClinicalTrials.gg INT008043

  • MeSH (NLM) D010959Tissue Plasminogen ActivatorOne source ClinicalTrials.gov

Also registered as alteplase (UNII 1RXS4UE564 · RxNorm 8410) and tissue-type plasminogen activator (UNII 1SBRUI0C8R).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.